Breast Reconstruction and Body Map : Assessment by Functional MRI (REMASCO)

Sponsor
Centre Oscar Lambret (Other)
Overall Status
Completed
CT.gov ID
NCT02553967
Collaborator
University Hospital, Lille (Other)
49
1
2
63.2
0.8

Study Details

Study Description

Brief Summary

Breast reconstruction is an integral part of the management of patients with breast cancer and treated by total mastectomy. The aim of breast reconstruction is to get a satisfying aesthetic and functional result (sensitivity) and that would enable the patient to appropriate the reconstructed breast. Patient satisfaction assessed subjectively by questionnaires would be better in autologous reconstructions than in reconstructions by prosthesis.

The aim of our trial is to use functional MRI (fMRI) as an objective evaluation tool to describe the brain functional changes of sensory projections after immediate or secondary breast reconstruction.

Condition or Disease Intervention/Treatment Phase
  • Device: Functional MRI
N/A

Detailed Description

Patients responding criteria for selection and not objecting to participate in this trial will address a quality of life questionnaire at baseline. Then the study procedures differ depending on which group the patient belongs to.

Immediate breast reconstruction group : Six months after surgery (or six months after the implantation of the definitive prosthesis in case of use of a tissue expander), a postoperative fMRI will be performed and patients will be asked to complete a quality of life form and a satisfaction form.

Secondary breast reconstruction group :
  • In the two months preceding the surgery, a preoperative fMRI will be performed.

  • Six months after surgery (or six months after the implantation of the definitive prosthesis in case of use of a tissue expander), a postoperative fMRI will be performed and patients will be asked to complete a quality of life form and a satisfaction form.

Study Design

Study Type:
Interventional
Actual Enrollment :
49 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Breast Reconstruction and Body Map : Assessment by Functional MRI (REMASCO)
Actual Study Start Date :
Jan 7, 2016
Actual Primary Completion Date :
Nov 25, 2019
Actual Study Completion Date :
Apr 15, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Immediate breast reconstruction

Total mastectomy + immediate reconstructive surgery 6 months after surgery : Functional MRI and questionnaires

Device: Functional MRI
Functional MRI

Experimental: Secondary breast reconstruction

Within 2 months before surgery : Functional MRI Reconstructive surgery 6 months after surgery : Functional MRI and questionnaires

Device: Functional MRI
Functional MRI

Outcome Measures

Primary Outcome Measures

  1. BOLD signal change (difference in intensity and anatomic location) in the regions activated during breast palpation between the reconstructed breast and the non-operated breast. [6 months]

Secondary Outcome Measures

  1. BOLD signal change (difference in intensity and anatomic location) in the regions activated during breast palpation between the breast reconstructed using an autologous flap and a prosthesis. [6 months]

  2. BOLD signal change (difference in intensity and anatomic location) in the regions activated during breast palpation between the reconstructed breast and the mastectomy scar before reconstruction. [6 months]

  3. Topography variation in brain sensory projection area after total mastectomy and breast reconstruction. [6 months]

  4. Satisfaction score and pre and postoperative quality-of-life score (Breast Q) according to a Likert scale. [6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Patient with an indication of unilateral total mastectomy with immediate breast reconstruction for initial breast cancer or recurrence, Or patient undergoing a unilateral secondary breast reconstruction

  2. WHO performance status less than or equal to 2

  3. Age ≥ 18 years

  4. For patients of childbearing age, use of an effective contraceptive method for the duration of the study

  5. Patient having been informed and having signed an informed consent form for the study.

Exclusion Criteria:
  1. Patient undergoing a breast reconstruction by exclusive lipomodelling

  2. Contraindication to MRI : claustrophobia, intra-orbital metallic fragment, pregnancy, cochlear implants, incompatible metallic foreign body such as certain pacemaker and mechanical valves

  3. Patient with an indication of preoperative radiotherapy or adjuvant chemotherapy according to regional and/or national standards

  4. History of brain surgery

  5. History of contralateral breast surgery

  6. History of prophylactic total mastectomy

  7. Reconstruction techniques using a mixed procedure (autologous + prosthesis)

  8. Patient on medication that may alter the BOLD signal in MRI

  9. Pregnant or breastfeeding women

  10. Patient under tutorship or guardianship

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Oscar Lambret Lille France 59020

Sponsors and Collaborators

  • Centre Oscar Lambret
  • University Hospital, Lille

Investigators

  • Principal Investigator: Claudia REGIS, MD, Centre Oscar Lambret

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Oscar Lambret
ClinicalTrials.gov Identifier:
NCT02553967
Other Study ID Numbers:
  • REMASCO-1503
First Posted:
Sep 18, 2015
Last Update Posted:
Oct 14, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Centre Oscar Lambret

Study Results

No Results Posted as of Oct 14, 2021